UroGen Pharma Ltd. — Investor Relations & Filings
Filings indexed
539
across all filing types
Latest filing
2026-05-06
Interim / Quarterly Rep…
Country
IL
Israel
Listing
US
URGN
UroGen Pharma Ltd. is a biopharmaceutical company focused on developing and commercializing treatments for urothelial and specialty cancers. The company aims to transform the treatment paradigm in uro-oncology by providing novel therapeutic options. Its approach is centered on the proprietary RTGel™ reverse-thermal hydrogel technology, which enables sustained local delivery of therapies. The company's commercial product, ZUSDURI™, is a treatment for recurrent Low-Grade, Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC). UroGen's clinical pipeline includes investigational candidates such as UGN-103, also being developed for LG-IR-NMIBC, as part of its commitment to advancing therapies for urologic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | |
| 8-K - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | |
| DEF 14A - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-04-30 | English | |
| 10-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | |
| 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | |
| 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 41828679 | 10-Q - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | ||
| 41825233 | 8-K - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | ||
| 39218358 | DEF 14A - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-04-30 | English | ||
| 32896251 | 10-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | ||
| 32896250 | 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | ||
| 32896249 | 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | ||
| 32896247 | 4 - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-02-27 | English | ||
| 32896248 | 4 - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-02-19 | English | ||
| 31213109 | 4 Filing | 2026-02-11 | English | ||
| 31213111 | 4 Filing | 2026-02-04 | English | ||
| 31213113 | 4 Filing | 2026-02-03 | English | ||
| 31213110 | 4 Filing | 2026-02-03 | English | ||
|
2025
3 filings
| |||||
| 12942222 | FORM 4 | 2025-12-01 | English | ||
| 12942226 | FORM 4 | 2025-12-01 | English | ||
| 12942227 | FORM 4 | 2025-12-01 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
UroGen Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for UroGen Pharma Ltd. (id: 32312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.